Companies / InspireMD, Inc. / Activity
Activity — InspireMD, Inc.
24 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 7, 2026 | Roubin Gary S Director | Buy | Common Stock | $106.2K | +90K +12.09% | 834,478 1.78% of shares | medium |
| May 7, 2026 | Ward Scott R. Director | Buy | Common Stock | $84.2K | +73K +44.71% | 237,096 0.51% of shares | medium |
| Jan 21, 2026 | Gleason Shane Thomas Executive | Sell | Common Stock | $28.6K | -18K -1.48% | 1,174,664 2.51% of shares | low |
| Jan 28, 2026 | Gleason Shane Thomas Executive | Sell | Common Stock | $20.5K | -12K -1.07% | 1,149,077 2.45% of shares | low |
| May 6, 2026 | Ward Scott R. Director | Buy | Common Stock | $18.4K | +16K +10.82% | 163,841 0.35% of shares | low |
| Jan 22, 2026 | Gleason Shane Thomas Executive | Sell | Common Stock | $13.2K | -8K -0.72% | 1,166,253 2.49% of shares | low |
| Jan 29, 2026 | Gleason Shane Thomas Executive | Sell | Common Stock | $8.3K | -5K -0.44% | 1,144,077 2.44% of shares | low |
| Jan 27, 2026 | Gleason Shane Thomas Executive | Sell | Common Stock | $8.0K | -5K -0.41% | 1,161,472 2.48% of shares | low |
| Dec 9, 2025 | Stuka Paul Director | Buy | Common Stock | $4.9K | +3K +0.70% | 391,628 0.84% of shares | low |
| Jan 30, 2026 | Gleason Shane Thomas Executive | Sell | Common Stock | $4.7K | -3K -0.25% | 1,141,177 2.44% of shares | low |
| Jan 20, 2026 | Gleason Shane Thomas Executive | Sell | Common Stock | $4.7K | -3K -0.25% | 1,192,257 2.55% of shares | low |
| Jan 15, 2026 | Gleason Shane Thomas Executive | Sell | Common Stock | $4.6K | -3K -0.24% | 1,197,462 2.56% of shares | low |
| Jan 16, 2026 | Gleason Shane Thomas Executive | Sell | Common Stock | $3.6K | -2K -0.19% | 1,195,212 2.55% of shares | low |
| Feb 2, 2026 | Gleason Shane Thomas Executive | Sell | Common Stock | $3.2K | -2K -0.18% | 1,139,177 2.43% of shares | low |
| Jan 14, 2026 | Slosman Marvin CEO | Grant | Restricted Stock Units | $0 | +1.1M +46.05% | 3,535,658 7.55% of shares | low |
| Jan 14, 2026 | Dearen Danny L. Director | Grant | Common Stock | $0 | +44K +75.89% | 102,047 0.22% of shares | low |
| Jan 14, 2026 | Stuka Paul Director | Grant | Common Stock | $0 | +132K +33.72% | 523,704 1.12% of shares | low |
| Jan 14, 2026 | Ward Scott R. Director | Grant | Common Stock | $0 | +88K +147.26% | 147,846 0.32% of shares | low |
| Jan 14, 2026 | Tommasoli Andrea Executive | Grant | Common Stock | $0 | +227K +31.15% | 954,389 2.04% of shares | low |
| Jan 14, 2026 | Roubin Gary S Director | Grant | Common Stock | $0 | +88K +13.41% | 744,478 1.59% of shares | low |
| Jan 14, 2026 | Lawless Michael A Executive | Grant | Common Stock | $0 | +227K +48.75% | 691,695 1.48% of shares | low |
| Jan 14, 2026 | Gleason Shane Thomas Executive | Grant | Common Stock | $0 | +453K +60.70% | 1,200,371 2.56% of shares | low |
| Jan 14, 2026 | Cohen Raymond W Director | Grant | Common Stock | $0 | +44K +91.00% | 92,417 0.20% of shares | low |
| Jan 14, 2026 | Berman Michael Director | Grant | Common Stock | $0 | +88K +33.29% | 352,586 0.75% of shares | low |